関連する実験動画

Updated: Feb 19, 2026

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

27.6K

多数の臓器-オン-ア-チップを統合することで,薬物間の相互作用を包括的に予測できる

Eric W Hsu1, Kai Wang1, Yik Pui Tsang1

  • 1Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA , USA.

Expert opinion on drug metabolism & toxicology
|February 17, 2026
PubMed
まとめ

多臓器・オン・チップ (MOC) プラットフォームは,生理学的に関連するデータを提供することによって,薬物相互作用 (DDI) を予測するより正確な方法を提供します. これらの高度なシステムは,既存の方法を補完し,医薬品の安全性を向上させます.

キーワード:
ADME ADME アドメ アドメIVIVEIVIVE IVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVEIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVIVPBPKモデリングPK/PDモデリングボディ・オン・ア・チップ薬物 薬物相互作用微生理学系とは,微生理学系である.モデルの情報に基づく薬物開発モデルマルチオルガン・オン・ア・チップオーガン・オン・ア・チップ

さらに関連する動画

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture10:05

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture

Published on: April 28, 2015

29.7K
Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality10:56

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality

Published on: May 5, 2022

14.9K

関連する概念動画

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.7K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
38
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
22